← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Traverse Biosciences, Inc.
Stony Brook, NY
$1,749,938
Total funding
3
Grants
Funding over time
peak $888.8K · FY2014–17$1M$750K$500K$250K$0
'14
'15
'16
'17
Funding mix
By agency
NIH$1,749,938 · 3
By mechanism
R42$1,320,432 · 1
R41$429,506 · 2
Investigators at Traverse Biosciences, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Pre-Clinical Safety and Efficacy of TRB-N0224 for the Treatment of Periodontal Disease$888,810
R42 · FY2016 · DE
Pre-Clinical Safety and Efficacy of TRB-N0224 for the Treatment of Periodontal Disease$431,622
R42 · FY2017 · DE
Evaluation of TRB-N0224, a Proprietary Chemically-Modified Curumin, for the Treat$223,797
R41 · FY2014 · AG
Evaluation of TRB-N0224, a Proprietary Chemically Modified Curcumin, for the Treatment of Periodontal Disease in a LPS-Induced Rat Model$205,709
R41 · FY2015 · DE